Atea Pharmaceuticals, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Atea Pharmaceuticals, Inc. | AVIR - NASDAQ |
$22.00-$24.00 | $24.00 | $27.02 | 12.5 million | 10/30/2020 |
| J.P. Morgan, Morgan Stanley, Evercore ISI, William Blair | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-10-09 Terms Added 2020-10-26 | ||||||
Atea Pharmaceuticals, Inc. Quote & Chart - Click for current quote - AVIR
IPO Boutique aggregates information on public companies and private companies, such as "AVIR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Atea Pharmaceuticals, Inc. (adapted from Atea Pharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AVIR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.